nvo market cap by year

Novo Nordisk A-S (NVO) has a market capitalization of $259.3B, based on 4.66B shares at a price of $55.61 (up 0.1% today).

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
September 2025
$56.04
253,992,100
4,662,705,135
$261,297,995,765.40
August 2025
$56.46
418,106,900
4,662,705,135
$263,239,079,913.10
July 2025
$46.54
371,108,700
4,662,705,135
$217,012,554,934.20
June 2025
$68.25
186,234,800
4,446,812,000
$303,477,576,433.20
May 2025
$70.70
239,163,700
4,446,812,000
$314,381,604,138.40
April 2025
$65.70
219,470,000
4,446,812,000
$292,177,337,778.80
March 2025
$68.66
148,675,300
4,446,400,000
$305,295,604,320.00
February 2025
$88.21
167,481,000
4,446,400,000
$392,225,836,800.00
January 2025
$82.18
189,740,600
4,446,400,000
$365,399,816,320.00
December 2024
$83.71
170,270,800
4,460,500,000
$373,373,289,300.00
November 2024
$103.93
121,015,600
4,460,500,000
$463,569,505,850.00
October 2024
$108.94
108,317,800
4,460,500,000
$485,923,301,600.00
September 2024
$115.87
78,552,600
4,460,500,000
$516,827,875,850.00
August 2024
$135.42
90,131,500
4,460,500,000
$604,029,312,700.00
July 2024
$128.58
92,171,100
4,460,500,000
$573,538,672,850.00
June 2024
$138.38
69,209,700
4,465,400,000
$617,936,341,280.00
May 2024
$131.15
83,582,700
4,465,400,000
$585,641,228,860.00
April 2024
$124.39
79,177,500
4,465,400,000
$555,467,181,440.00
March 2024
$124.48
117,271,100
4,470,500,000
$556,491,863,450.00
February 2024
$115.28
105,941,600
4,470,500,000
$515,370,416,250.00
January 2024
$110.44
96,116,000
4,470,500,000
$493,726,490,500.00
December 2023
$99.57
73,612,200
4,477,400,000
$445,832,627,600.00
November 2023
$98.02
99,922,200
4,477,400,000
$438,894,000,820.00
October 2023
$92.95
113,059,800
4,477,400,000
$416,182,389,320.00
September 2023
$87.53
89,019,400
4,489,000,000
$392,934,290,300.00